Conformational Restriction Leading to a Selective CB2 Cannabinoid Receptor Agonist Orally Active Against Colitis

J El Bakali, GG Muccioli, M Body-Malapel… - ACS Medicinal …, 2015 - ACS Publications
The CB2 cannabinoid receptor has been implicated in the regulation of intestinal
inflammation. Following on from the promising activity of a series of 4-oxo-1, 4 …
被引用次数：30 相关文章

Conformational Restriction Leading to a Selective CB2 Cannabinoid Receptor Agonist Orally Active Against Colitis.

J El Bakali, GG Muccioli, M Body-Malapel… - ACS Medicinal …, 2014 - europepmc.org
Conformational Restriction Leading to a Selective CB2 Cannabinoid Receptor Agonist Orally
Active Against Colitis. - Abstract - Europe PMC Sign in | Create an account https://orcid.org …
[PDF] amazonaws.com

[PDF][PDF] Conformational Restriction Leading to a Selective CB2 Cannabinoid Receptor Agonist Orally Active Against Colitis

J El Bakali, GG Muccioli, M Body-Malapel, M Djouina… - pstorage-acs-6854636.s3 …
General Information. All commercial reagents and solvents were used without further
purification. Analytical thin-layer chromatography was performed on precoated Kieselgel …

Conformational Restriction Leading to a Selective CB 2 Cannabinoid Receptor Agonist Orally Active Against Colitis

J El Bakali, GG Muccioli, M Body-Malapel… - ACS Medicinal …, 2015 - hal.science
The CB2 cannabinoid receptor has been implicated in the regulation of intestinal
inflammation. Following on from the promising activity of a series of 4-oxo-1, 4 …

[引用][C] Conformational Restriction Leading to a Selective CB2 Cannabinoid Receptor Agonist Orally Active Against Colitis

J El Bakali, G Muccioli Giulio, M Body-Malapel… - 2015 - lilloa.univ-lille.fr
Conformational Restriction Leading to a Selective CB2 Cannabinoid Receptor Agonist Orally
Active Against Colitis Toggle navigation English français Aide | Contact | À Propos | Ouvrir une …

Conformational Restriction Leading to a Selective CB2 Cannabinoid Receptor Agonist Orally Active Against Colitis

J El Bakali, GG Muccioli… - ACS medicinal …, 2014 - pubmed.ncbi.nlm.nih.gov
The CB2 cannabinoid receptor has been implicated in the regulation of intestinal
inflammation. Following on from the promising activity of a series of 4-oxo-1, 4 …
[HTML] nih.gov

[HTML][HTML] Conformational Restriction Leading to a Selective CB2 Cannabinoid Receptor Agonist Orally Active Against Colitis

J El Bakali, GG Muccioli, M Body-Malapel… - ACS Medicinal …, 2015 - ncbi.nlm.nih.gov
Conformational Restriction Leading to a Selective CB2 Cannabinoid Receptor Agonist Orally
Active Against Colitis - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI …
[PDF] academia.edu

[PDF][PDF] Conformational Restriction Leading to a Selective CB2 Cannabinoid Receptor Agonist Orally Active Against Colitis

J El Bakali, GG Muccioli, M Body-Malapel, M Djouina… - 2014 - academia.edu
The CB2 cannabinoid receptor has been implicated in the regulation of intestinal
inflammation. Following on from the promising activity of a series of 4-oxo-1, 4 …

Conformational Restriction Leading to a Selective CB2 Cannabinoid Receptor Agonist Orally Active Against Colitis

J El Bakali, G Muccioli, M Body-Malapel… - ACS Medicinal …, 2015 - dial.uclouvain.be
The CB2 cannabinoid receptor has been implicated in the regulation of intestinal
inflammation. Following on from the promising activity of a series of 4-oxo-1, 4 …

[引用][C] Conformational Restriction Leading to a Selective CB2 Cannabinoid Receptor Agonist Orally Active Against Colitis

J El Bakali, G Muccioli Giulio, M Body-Malapel… - 2015 - lilloa.univ-lille.fr
Conformational Restriction Leading to a Selective CB2 Cannabinoid Receptor Agonist Orally
Active Against Colitis Toggle navigation English français Aide | Contact | À Propos | Ouvrir une …